NET PROFIT (x1000 SEK)
EMPLOYEES
Molymedic AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-17
|
-12
|
-8 |
| EBITDA |
-17
|
-12
|
-8 |
| Total assets |
227
|
127
|
133 |
| Current assets |
227
|
127
|
133 |
| Current liabilities |
144
|
26
|
20 |
| Equity capital |
83
|
101
|
113 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.6%
|
79.5%
|
85.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-7.5%
|
-9.4%
|
-6.0% |
| Current ratio |
157.6%
|
488.5%
|
665.0% |
| Return on equity (ROE) |
-20.5%
|
-11.9%
|
-7.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.